Pexa AB
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PEXAB.ST research report →
Companywww.pexa.se
Pexa AB engages in the development and commercialization of technology in the field of respiratory medicine. It provides lung researchers with a simple and non-invasive method for collection of microscopic particles, potential biomarkers for diseases in the small airways. The company was founded by Anna-Carin Olin in 2010 and is headquartered in Gothenburg, Sweden.
- CEO
- Bengt Tomas Jan Gustafsson
- HQ
- SE
Price Chart
Valuation
- Market Cap
- $10.48M
- P/E
- -2.41
- P/S
- 13.42
- P/B
- 4.94
- EV/EBITDA
- -1.22
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -703.82%
- Op Margin
- -986.89%
- Net Margin
- -962.36%
- ROE
- -126.17%
- ROIC
- -210.35%
Growth & Income
- Revenue
- $719.62K · -64.29%
- Net Income
- $-10,162,729 · -26.35%
- EPS
- $-0.14 · 6.67%
- Op Income
- $-10,451,285
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.55
- 52W Low
- $0.16
- 50D MA
- $0.24
- 200D MA
- $0.29
- Beta
- 1.02
- Avg Volume
- 64.56K
Get TickerSpark's AI analysis on PEXAB.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PEXAB.ST Coverage
We haven't published any research on PEXAB.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PEXAB.ST Report →